Aquarius Surgical Technologies Inc. (AQQRF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Aquarius Surgical Technologies Inc. (AQQRF) trades at $0.00 with AI Score 46/100 (Grade C). Aquarius Surgical Technologies Inc. develops, sells, and distributes medical laser solutions across multiple disciplines in Canada and the United States. Market cap: $115,917, Sector: Healthcare.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for AQQRF: AQQRF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates AQQRF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
AQQRF: the 1 perspectives are evenly split.
How is this calculated? →Aquarius Surgical Technologies Inc. (AQQRF) Healthcare & Pipeline Overview
Aquarius Surgical Technologies Inc. focuses on developing and marketing medical laser technologies across various surgical disciplines in North America. With a negative P/E ratio and a high beta, the company navigates a competitive landscape while seeking growth opportunities in specialized medical fields.
What Is the Investment Thesis for AQQRF?
Aquarius Surgical Technologies Inc. presents a speculative investment opportunity within the medical device sector. The company's negative P/E ratio of -1.77 and a negative profit margin of -277.1% indicate financial challenges, while a gross margin of 53.8% suggests potential in its core operations. The high beta of 1.69 reflects significant volatility relative to the market. Growth catalysts include expanding its product line and penetrating new geographic markets. Key risks involve competition from larger players and the need to achieve profitability. Investors should carefully assess the company's ability to improve its financial performance and capitalize on growth opportunities within the next 3-5 years.
Based on FMP financials and quantitative analysis
AQQRF Key Highlights
- Gross Margin of 53.8% indicates potential profitability in core operations despite overall losses.
- Negative P/E Ratio of -1.77 reflects current losses and challenges in achieving profitability.
- High Beta of 1.69 suggests the stock is more volatile than the market average.
- Profit Margin of -277.1% highlights significant operational inefficiencies and losses.
- Market Cap of 116K indicates the company is a micro-cap stock with limited financial resources.
Who Are AQQRF's Competitors?
AQQRF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| DCTH Delcath Systems, Inc. | $13.61 | +3.11% | $469.84M | 73 |
| PYNKF Perimeter Medical Imaging AI, Inc. | $0.20 | +3.40% | $18.68M | 73 |
| SSII SS Innovations International, Inc. | $3.76 | -0.53% | $752.49M | 72 |
| RSHUF Respiri Limited | $0.06 | +0.00% | $91.52M | 68 |
| EW Edwards Lifesciences Corporation | $95.44 | +1.14% | $54.96B | 58 |
| PETV PetVivo Holdings, Inc. | $0.80 | -4.65% | $24.03M | 58 |
| AXGN AxoGen, Inc. | $45.08 | -1.77% | $2.40B | 58 |
| NXL Nexalin Technology, Inc. | $0.35 | -3.07% | $7.20M | 59 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are AQQRF's Key Strengths?
- Specialized laser technology for niche surgical applications.
- Established presence in Canada and the United States.
- Expertise in laser-based surgical solutions.
- Gross margin above 50%.
What Are AQQRF's Weaknesses?
- Negative profit margin and net losses.
- Small market capitalization and limited financial resources.
- High beta indicating significant stock volatility.
- Dependence on a limited number of products and markets.
What Could Drive AQQRF Stock Higher?
- Expansion of product offerings in laser-based surgical solutions.
- Strategic partnerships with hospitals and medical centers to increase market penetration.
- Potential regulatory approvals for new laser technologies in development.
What Are the Key Risks for AQQRF?
- Financial-distress signal — its Altman Z-Score of -31.36 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Intense competition from larger medical device companies.
- Dependence on regulatory approvals for new products.
- Negative profit margin and net losses.
- Limited financial resources and small market capitalization.
What Are the Growth Opportunities for AQQRF?
- Expansion into New Therapeutic Areas: Aquarius Surgical Technologies can expand its market reach by developing laser solutions for additional medical specialties, such as dermatology and cosmetic surgery. The global market for aesthetic lasers is projected to reach $3.5 billion by 2028, offering a significant growth opportunity. Timeline: 2-3 years.
- Geographic Expansion: The company can increase its revenue by entering new geographic markets, particularly in Europe and Asia, where demand for advanced surgical technologies is growing. The Asia-Pacific medical device market is expected to be the fastest-growing region, presenting a lucrative opportunity. Timeline: 3-5 years.
- Product Line Diversification: Aquarius Surgical Technologies can diversify its product line by developing complementary products and accessories for its laser systems, such as specialized handpieces and software solutions. This can increase revenue per customer and enhance customer loyalty. Timeline: 1-2 years.
- Strategic Partnerships: The company can form strategic partnerships with hospitals, clinics, and medical device distributors to expand its sales and distribution network. This can provide access to new customers and markets, accelerating revenue growth. Timeline: Ongoing.
- Technological Innovation: Aquarius Surgical Technologies can invest in research and development to develop next-generation laser technologies that offer improved precision, safety, and efficacy. This can create a competitive advantage and attract new customers. Timeline: Ongoing.
What Opportunities Does AQQRF Have?
- Expansion into new therapeutic areas and geographic markets.
- Development of next-generation laser technologies.
- Strategic partnerships with hospitals and distributors.
- Increasing demand for minimally invasive surgical procedures.
What Threats Does AQQRF Face?
- Competition from larger, more established medical device companies.
- Stringent regulatory requirements and approval processes.
- Technological obsolescence.
- Economic downturns and healthcare spending cuts.
What Are AQQRF's Competitive Advantages?
- Specialized laser technology for niche surgical applications.
- Established relationships with hospitals and clinics in Canada and the United States.
- Proprietary technology and intellectual property.
- Expertise in laser-based surgical solutions.
What Does AQQRF Do?
Aquarius Surgical Technologies Inc., established in 1986 and based in Toronto, Canada, operates through its subsidiary, Surgical Lasers Inc., to develop, sell, and distribute medical laser technologies. The company provides solutions for a range of medical disciplines, including urology, gynecology, ophthalmology, thoracic, ENT, cardiovascular, and neurosurgery. These laser systems are utilized in surgical and other medical environments across Canada and the United States. Formerly known as Aquarius Coatings Inc., the company transitioned to focus on the medical device sector, specifically laser-based surgical solutions. Aquarius Surgical Technologies aims to provide advanced surgical tools that enhance precision and patient outcomes. The company's market position is focused on niche applications within these specialized surgical fields, competing with larger medical device manufacturers while seeking to establish a strong presence through innovation and targeted marketing efforts.
What Products and Services Does AQQRF Offer?
- Develops medical laser technologies for surgical applications.
- Sells and distributes laser systems in Canada and the United States.
- Offers solutions for urology, gynecology, ophthalmology, and other surgical disciplines.
- Provides laser technology for minimally invasive surgical procedures.
- Markets its products to hospitals, clinics, and surgical centers.
- Focuses on laser-based solutions for various medical specialties.
How Does AQQRF Make Money?
- Direct sales of laser systems to hospitals and clinics.
- Distribution through partnerships with medical device distributors.
- Service and maintenance contracts for installed laser systems.
- Sales of consumables and accessories for laser systems.
What Industry Does AQQRF Operate In?
Aquarius Surgical Technologies Inc. operates in the competitive medical device industry, which is characterized by rapid technological advancements and stringent regulatory requirements. The global medical devices market is projected to reach $600 billion by 2026, driven by an aging population and increasing demand for minimally invasive surgical procedures. Key competitors include larger, more established companies with broader product portfolios. Aquarius Surgical Technologies focuses on niche applications within laser surgery, differentiating itself through specialized solutions and targeted marketing. The company's success depends on its ability to innovate, obtain regulatory approvals, and effectively commercialize its products.
Who Are AQQRF's Key Customers?
- Hospitals and surgical centers.
- Private medical clinics.
- Individual surgeons and physicians.
- Medical device distributors.
Aquarius Surgical Technologies Inc. (AQQRF) Valuation Context
Valued at 116K, AQQRF is classified as a micro-cap stock. Relative to its peer group, AQQRF's quantitative score of 46/100 is below the peer average of 69/100.
AQQRF Revenue & Earnings Trend
In Q4 2025, AQQRF generated $23K in top-line revenue, marking a sequential increase of 21.2%. The company recorded a net loss of $585K, with diluted EPS of $-0.02. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this micro-cap Healthcare company. Across the four most recent quarters, AQQRF averaged $-0.01 in diluted EPS.
Company Profile
Aquarius Surgical Technologies Inc. operates in the Medical - Devices industry within the Healthcare sector. It is headquartered in Toronto, CA. The company is led by CEO Lorne Stewart MacFarlane. AQQRF has traded publicly since 2017.
ROE 0%Key Financial Metrics
Return on equity for Aquarius Surgical Technologies Inc. stands at 0.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -0.5%, showing how much profit it generates from its asset base. Its free cash flow yield is -65.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.05 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -3.2%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 2/9Financial Health
Aquarius Surgical Technologies Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -31.36 places it in the distress zone, a signal of elevated financial risk.
AQQRF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests strong confidence in the company's future, indicating that executives believe in the growth potential of Aquarius Surgical Technologies.
- Community sentiment has shifted positively, with discussions highlighting innovative product developments that could disrupt the surgical technology market.
- There is increasing interest from healthcare professionals who are sharing positive experiences with the company's products, enhancing its reputation.
- Market perception is buoyed by recent partnerships that may expand distribution channels, reflecting optimism about future sales.
Bear Case
- Concerns about regulatory challenges in the medical device sector have been raised, which could hinder the company's ability to bring new products to market.
- A lack of strong financial performance metrics in recent reports has led some investors to question the sustainability of growth.
- Social sentiment has seen a few bearish voices cautioning against overvaluation based on current market hype surrounding the surgical tech space.
- Recent competitive entries into the market have sparked fears that Aquarius may struggle to maintain its market share against established players.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $22,712 | -$584,754 | -$0.02 |
| Q3 2025 | $18,745 | -$808,500 | -$0.03 |
| Q2 2025 | $17,625 | $712,026 | $0.03 |
| Q1 2025 | $15,940 | -$482,016 | -$0.02 |
Based on FMP financials and quantitative analysis
AQQRF Latest News
No recent news available for AQQRF.
AQQRF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for AQQRF.
Price Targets
Wall Street price target analysis for AQQRF.
AQQRF MoonshotScore
What does this score mean?
The MoonshotScore rates AQQRF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Lorne Stewart MacFarlane
CEO
Lorne Stewart MacFarlane has served as the CEO of Aquarius Surgical Technologies Inc. His background includes experience in corporate management and strategic development within the healthcare sector. He has focused on guiding the company through its transition and growth phases, emphasizing innovation and market expansion. His expertise lies in identifying opportunities for technological advancement and implementing strategies to enhance the company's market position.
Track Record: Under Lorne Stewart MacFarlane's leadership, Aquarius Surgical Technologies has focused on expanding its product offerings and strengthening its distribution network. Key milestones include securing partnerships with key medical institutions and navigating regulatory approvals for new laser technologies. His strategic decisions have aimed to improve the company's financial performance and market competitiveness.
AQQRF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Aquarius Surgical Technologies Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited regulatory oversight and may not be required to provide regular financial disclosures. This tier is often associated with higher risk and greater potential for volatility compared to stocks listed on major exchanges like NYSE or NASDAQ.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited regulatory oversight and disclosure requirements.
- Potential for price manipulation and fraud.
- Higher volatility and lower liquidity compared to exchange-listed stocks.
- Increased risk of financial distress or bankruptcy.
- Difficulty in obtaining reliable information about the company's financials and operations.
- Verify the company's registration and legal status.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Check for any legal or regulatory issues.
- Monitor trading volume and price volatility.
- Consult with a financial advisor.
- Company has been in operation since 1986.
- Focus on a specific niche within the medical device industry.
- Presence in Canada and the United States.
- Gross margin above 50% suggests potential for profitability.
What Investors Ask About Aquarius Surgical Technologies Inc. (AQQRF) — Healthcare
What does Aquarius Surgical Technologies Inc. do?
Aquarius Surgical Technologies Inc., through its subsidiary Surgical Lasers Inc., develops, sells, and distributes medical laser technologies for various surgical applications. The company focuses on providing solutions for urology, gynecology, ophthalmology, and other medical disciplines in Canada and the United States. Their business model centers around direct sales and distribution partnerships, targeting hospitals, clinics, and individual surgeons to integrate advanced laser technology into their practices.
What do analysts say about AQQRF stock?
There is currently no available analyst coverage for AQQRF. Given the company's OTC listing and small market capitalization, it is not widely followed by analysts. Investors should conduct their own thorough research and due diligence before investing in AQQRF, considering the limited information available and the inherent risks associated with micro-cap stocks. Key valuation metrics to consider include the company's gross margin, revenue growth, and path to profitability.
What are the main risks for AQQRF?
The main risks for Aquarius Surgical Technologies Inc. include intense competition from larger medical device companies with greater resources, the need to obtain regulatory approvals for new products, ongoing financial losses, and limited financial resources. The company's small market capitalization and OTC listing also contribute to higher volatility and liquidity risks. Investors should carefully assess these risks before investing in AQQRF.
What are the key factors to evaluate for AQQRF?
Aquarius Surgical Technologies Inc. (AQQRF) holds an AI score of 46/100 (low). Not financial advice.
How frequently does AQQRF data refresh on this page?
AQQRF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven AQQRF's recent stock price performance?
Aquarius Surgical Technologies Inc. (AQQRF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized laser technology for niche surgical applications. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider AQQRF overvalued or undervalued right now?
Valuing Aquarius Surgical Technologies Inc. (AQQRF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying AQQRF?
Before investing in Aquarius Surgical Technologies Inc. (AQQRF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available for this OTC-listed company.
- Financial data may not be up-to-date or readily accessible.
- AI analysis pending for AQQRF.